Lessons to learn: COVID-19 epidemic in Italy

Cover Page

Cite item


Here we provide the assessment of COVID-19 epidemic in Italy, which scale has led to serious challenges both for society and national health care system. Despite timely information regarding the pandemic spread of the novel coronavirus infection, the country’s health care was not prepared to dramatically increased rate of patients with viral pneumonia at the first stage of the epidemic, infection control measures were not fully implemented that also led to spread of infection among health care workers. Socially vulnerable population groups did not seek timely medical care due to the lack of hospital facilities as well as well-trained medical personnel. At the second stage of developing epidemic, were also delayed and executed at varying timepoints in neighbor regions, with sustained insufficient management after implementing them that was reflected as ongoing rise of epidemic curve over long time. Delayed execution of anti-epidemic restrictive measures aimed at fighting against ongoing epidemic resulted in substantially increased morbidity and mortality among vulnerable population groups and retarded rate of decreasing COVID-19 epidemic curve. Analyzing response measures taken in Italy against COVID-19 epidemic should be appreciated by other countries while dealing with the current pandemic and preparing to react to novel biological threats in the future.

About the authors

A. V. Semenov

St. Petersburg Pasteur Institute, St;
North-Western State Medical University named after I.I. Mechnikov

Author for correspondence.
Email: alexvsemenov@gmail.com
ORCID iD: 0000-0003-3223-8219

Semenov Alexander V., PhD (Biology), Deputy Director for Innovation, Head of the Laboratory of Virology and Immunology HIV, St. Petersburg Pasteur Institute; Professor, Department of Immunology, Pavlov First St. Petersburg State Medical University

197101, St. Petersburg, Mira str., 14

Russian Federation

N. Y. Pshenichnaya

Central Research Institute of Epidemiology and Microbiology;
Rostov State Medical University, Ministry of Health of Russia

Email: natalia-pshenichnaya@yandex.ru
ORCID iD: 0000-0003-2570-711X

PhD, MD (Medicine), Professor, Deputy Director for Clinical and Analytical Work, Central Research Institute of Epidemiology and Microbiology; Leading Researcher, Central Research Laboratory, Rostov State Medical University

Moscow, Rostov-on-Don

Russian Federation


  1. Boccia S., Ricciardi W., Ioannidis J.P. What other countries can learn from Italy during the COVID-19 pandemic. JAMA Int.Med. 2020 Apr 7. doi: 10.1001/jamainternmed.2020.1447
  2. Capobianchi M.R., Rueca M., Messina F., Giombini E., Carletti F., Colavita F., Castilletti C., Lalle E., Bordi L., Vairo F., Nicastri E. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin. Microbiol. Infect., 2020 Mar 27.
  3. Cesari M., Proietti M. COVID-19 in Italy: ageism and decision-making in a pandemic. J. Am. Med. Dir. Assoc., 2020 Apr 1.
  4. Crisanti A., Cassone A. In one Italian town, weshowed mass testing could eradicate the coronavirus. The Guardian. March 20, 2020.Accessed April 2, 2020. URL: https://www.theguardian.com/commentisfree/2020/mar/20/eradicatedcoronavirus-mass-testing-covid-19-italy-vo
  5. Epidemia COVID-19, aggiornamento nazionale:30 marzo 2020. Task force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica, Istituto Superiore di Sanità. Accessed April 2, 2020. URL: https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianzaintegrata-COVID-19_30-marzo-2020.pdf
  6. La Marca A., Niederberger C., Pellicer A., Nelson S.M. COVID-19: lessons from the Italian reproductive medical experience. Fertil. Steril., 2020, vol. 113, no. 5, pp. 920–922.
  7. Lazzerini M., Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet, 2020, vol. 8, iss. 5, e641– e642. doi: 10.1016/S2214-109X(20)30110-8
  8. Nacoti M., Ciocca A., Giupponi A., Brambillasca P., Lussana F., Pisano M., Goisis G., Bonacina D., Fazzi F., Naspro R., Longhi L. At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catalyst Innovations in Care Delivery. 2020 Mar 21.
  9. Paterlini M. On the front lines of coronavirus: the Italian response to COVID-19. BMJ, 2020 Mar 16.
  10. Pisano G.P., Sadun R., Zanini M. Lessons from Italy’s response to coronavirus. Harvard Business Review, 2020 Mar 27. URL: https://hbr.org/2020/03/lessons-from-italys-response-to-coronavirus
  11. ProMED-mail. COVID-19 update (14): China, global, Iran, Italy, WHO. ProMED-mail 2020; 31 Jan: 20200223.7015552
  12. ProMED-mail. COVID-19 update (14): China, global, Iran, Italy, WHO. ProMED-mail 2020; 23 Feb: 20200223.7015552
  13. ProMED-mail. Novel coronavirus (25): updates, China, Italy, Russia, UK. ProMED-mail 2020; 31 Jan: 20200131.6940058
  14. Remuzzi A., Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020 Mar 13.
  15. Semenov A.V., Pshenichnaya N.Yu. Born in Wuhan: lessons from COVID-19 epidemic in China. Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2020, vol. 10, no. 2, pp. 210–220. doi: 10.15789/2220-7619-BIW-1453
  16. Sorveglianza integrata COVID-19: I principali dati nazionali. Instituto Superiore di Sanità. March 11,2020. Accessed April 2, 2020.
  17. Spina S., Marrazzo F., Migliari M., Stucchi R., Sforza A., Fumagalli R. The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. Lancet, 2020, vol. 395, iss. 10227: e49–e50.
  18. United Nations: United Nations Population Division. World Population Prospects 2019
  19. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 11 March 2020. Geneva, Switzerland. 2020 Mar. URL: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19---11-march-2020

Copyright (c) 2020 Semenov A.V., Pshenichnaya N.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies